StockData
Actuate Therapeutics, Inc. logo

Actuate Therapeutics, Inc. (ACTU) income statement

ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.23+0.01 (+5.38%)

Close on Nov 20, 2026Market cap $5.41MP/E –Yield –

See a number that looks wrong?